Archives

by in
Entry Author Date Location
Dendreon Shares Fall Again, as Provenge Sales Slump 05/09/13 Seattle
See Clay Siegall, Kim Popovits, Mitch Gold This Afternoon 04/09/13 Seattle
Adaptive Biotechnologies Reaches Fork in the Road. What to Charge? 04/03/13 Seattle
What’s Hot in Digital Health? The Venture Capital Perspective 12/11/12 San Francisco
CardioDx Pockets $58M, Right After Medicare OK 08/27/12 San Francisco
CardioDx Wins Medicare OK of Molecular Test for Heart Disease 08/08/12 San Francisco
Wireless Health Summit Showcases Incentive Prizes as Tool for Change 05/21/12 San Diego
Driving for a Better Way to Engage Consumers in their Own Health 04/17/12 National
Genomic Health Wins Medicare Coverage for High-Priced Colon Cancer Test 09/30/11 San Francisco
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus 08/08/11 National
Dendreon Takes Huge Hit, Stock Tanks 60% on Sales Shortfall 08/03/11 Seattle
SeaGen Preserves Science Culture, Dendreon Sways Medicare, NanoString’s Financing, & More Seattle-Area Life Sciences News 07/07/11 Seattle
Dendreon Wins Full Reimbursement From Medicare for $93K Prostate Cancer Drug 03/30/11 Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News 11/18/10 Seattle
Dendreon Passes Medicare Panel’s Questions About Provenge Effectiveness 11/17/10 Seattle
Dendreon Prepares to Take Some Heat in the Other Washington Over Cancer Drug Prices 11/16/10 Seattle
Dendreon’s Provenge Launch Story Enters Second Chapter, With Today’s Earnings Call 11/03/10 Seattle
Athenahealth Taps Sermo Docs for Opinions on Electronic Health Records 03/01/10 Boston
eClinicalWorks Tops $100M Sales as Doctors Move from Paper to Pixel Records 02/05/10 Boston
IkaSystems Gets Capital Infusions from Essex Woodlands Health Ventures and Providence Equity Partners 01/19/10 Boston
Ekos, Enduring Tough Year for Devices, Sticks With Goal to Break Even Next Year 11/30/09 Seattle
How Did Calypso Raise $50M? The Story Behind Seattle’s Biggest VC Deal of 2009 09/18/09 Seattle
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 2 07/28/09 Seattle
Amag Pharmaceuticals Wins FDA Approval to Sell Iron Deficiency Drug 06/30/09 Boston
Genzyme Enters Seattle Hub, Oncothyreon Bets on Cancer Drugs, Pathway Nabs $40M, & More Seattle-Area Life Sciences News 04/02/09 Seattle
Riding a Cancer Diagnostics Wave, Genoptix Sees Boom Continuing in 2009 04/01/09 San Diego
Calypso Gets Florida Medicare Unit to Pay for “GPS for the Body” for Prostate Cancer 03/27/09 Seattle
Congress Overrides Bush Veto on Medicare Bill, Cell Therapeutics’ Zevalin Reimbursement Survives 07/16/08 Seattle
Cell Therapeutics Gets a Win on Capitol Hill, Zevalin Reimbursement To Remain Same 07/09/08 Seattle
Calypso Medical’s “GPS For the Body” Gaining Ground With Radiation Doctors 06/25/08 Seattle
Page 1 of 2 next page »